Literature DB >> 3976590

Consequences of candidemia for pediatric patients.

R B Turner, L G Donowitz, J O Hendley.   

Abstract

The hospital records of 45 infants and children with one or more blood cultures positive for Candida species were studied retrospectively in an attempt to define the risk of Candida-related complications. Death of eight of the patients (18%) was related to Candida infection, and five additional patients (11%) had metastatic foci of infection but survived. No characteristics were identified that would predict patients who were at high risk for complications of candidemia. Eleven patients were treated with amphotericin B for longer than a week and were examined for evidence of nephrotoxicity. None had persistent abnormalities of blood urea nitrogen or serum creatinine concentrations develop during treatment; two patients had hypokalemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976590     DOI: 10.1001/archpedi.1985.02140040080032

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  7 in total

1.  Nonvalue of antigen detection immunoassays for diagnosis of candidemia.

Authors:  P Phillips; A Dowd; P Jewesson; G Radigan; M G Tweeddale; A Clarke; I Geere; M Kelly
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

2.  Fluconazole in the treatment of candidiasis in immunocompromised children.

Authors:  C Viscoli; E Castagnola; F Fioredda; B Ciravegna; G Barigione; A Terragna
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.

Authors:  Theoklis E Zaoutis; Priya A Prasad; A Russell Localio; Susan E Coffin; Louis M Bell; Thomas J Walsh; Robert Gross
Journal:  Clin Infect Dis       Date:  2010-09-01       Impact factor: 9.079

4.  Amphotericin B in Pediatrics: Analysis by Age Stratification Suggests a Greater Chance of Adverse Events from 13 Months of Age Onwards.

Authors:  Francelise Bridi Cavassin; João Luiz Baú-Carneiro; Fabio de Araújo Motta; Ana Paula Matzenbacher Ville; Leticia Staszczak; Flávio de Queiroz-Telles
Journal:  Paediatr Drugs       Date:  2022-07-18       Impact factor: 3.930

Review 5.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Candida strains from neonates in a special care baby unit.

Authors:  A M Sharp; F C Odds; E G Evans
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

Review 7.  Nosocomial infections in pediatric intensive care units.

Authors:  R Lodha; U C Natchu; M Nanda; S K Kabra; U Chandra; M Natchu
Journal:  Indian J Pediatr       Date:  2001-11       Impact factor: 1.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.